Successful reoperation using homografts for tricuspid and pulmonary valve regurgitation after radical double outlet right ventricle correction
K. V. Shatalov,
I. V. Arnautova,
S. V. Patsera,
K. M. Dzhidzhikhiya,
R. R Akhtiamov,
V. A. Bolsunovskii,
D. V. Zotov,
Yu. V. Gusarova https://doi.org/10.15825/1995-1191-2025-4-196-200
Abstract
Currently, there is a growing number of repeat cardiac interventions in children who have previously undergone surgery for congenital heart defects. This has renewed interest in identifying reconstructive materials that are resistant to the host’s defense mechanisms. Among such materials, cryopreserved homografts in various modifi cations are of particular relevance. Numerous studies have reported on the use of these prostheses in diff erent anatomical positions; however, cases involving simultaneous implantation of multiple homografts in a single patient for correction of congenital heart defects remain rare. To our knowledge, there are no published reports describing the use of a mitral homograft as a tricuspid valve substitute in combination with prosthetic pulmonary valve replacement using an allograft conduit. This report presents the first successful case of double valve replacement in a pediatric patient who had previously undergone radical correction of a double outlet right ventricle.
About the Authors
K. V. Shatalov
Bakulev National Medical Research Center for Cardiovascular Surgery
Russian Federation
Russian Federation
Moscow
I. V. Arnautova
Bakulev National Medical Research Center for Cardiovascular Surgery
Russian Federation
Russian Federation
Moscow
S. V. Patsera
Bakulev National Medical Research Center for Cardiovascular Surgery
Russian Federation
Russian Federation
Sergey Patsera
Address: 135, Rublevskoe Shosse, Moscow, 121552
K. M. Dzhidzhikhiya
Bakulev National Medical Research Center for Cardiovascular Surgery
Russian Federation
Russian Federation
Moscow
R. R Akhtiamov
Bakulev National Medical Research Center for Cardiovascular Surgery
Russian Federation
Russian Federation
Moscow
V. A. Bolsunovskii
Pediatric City Multidisciplinary Clinical Specialized Center for Advanced Medical Technologies
Russian Federation
Russian Federation
St. Petersburg
D. V. Zotov
Bakulev National Medical Research Center for Cardiovascular Surgery
Russian Federation
Russian Federation
Moscow
Yu. V. Gusarova
Bakulev National Medical Research Center for Cardiovascular Surgery
Russian Federation
Russian Federation
Moscow
References
1. Ross DN, Somerville J. Correction of pulmonary atresia with a homograft aortic valve. Lancet. 1966 Dec 31; 2 (7479): 1446–1447. doi: 10.1016/s01406736(66)90600-3.
2. Rajashekar P, Gupta A, Velayoudam D. Choice of valve substitutes. Indian J Thorac Cardiovasc Surg. 2024 May; 40 (Suppl 1): 78–82. doi: 10.1007/s12055-02401733-6.
3. Huber R, Rothlin M, Senning A. Spätresultate nach Atrioventrikulärklappenersatz mit Mitralallotransplantat. Thorac Cardiovasc Surg. 1975 Feb; 23 (1): 33–38. doi: 10.1055/s-0028-1096923.
4. Pomar JL, Mestres CA. Tricuspid valve replacement using a mitral homograft. Surgical technique and initial results. J Heart Valve Dis. 1993 Mar; 2 (2): 125–128. PMID: 8261148.
5. Hvass U, Lansac E, Chatel D, Henri I. Mitral homograft for tricuspid valve endocarditis complicating a congenital fistula between the right coronary artery and right ventricle. J Heart Valve Dis. 1996 Sep; 5 (5): 564–566. PMID: 8895001.
6. Shamsiev GA, Muratov RM, Amiragov RI, Babenko SI. Long-term result of surgical treatment of tricuspid valve infective endocarditis with cryopreserved mitral homograft. Russian Journal of Thoracic and Cardiovascular Surgery. 2014; 56 (4): 52–55. (in Russ.).
7. Shatalov KV, Bolsunovsky VA, Gamisoniya AM, Arnautova IV, Akhtyamov RR. The first experience of implantation of a mitral homograft in the tricuspid position in children. Russian Journal of Thoracic and Cardiovascular Surgery. 2023; 65 (5): 589–594. (in Russ.). doi: 10.24022/0236-27912023-65-5-589-594.
8. Jashari R. Transplantation of cryopreserved human heart valves in Europe: 30 years of banking in Brussels and future perspectives. Cell Tissue Bank. 2021 Dec; 22 (4): 519–537. doi: 10.1007/s10561-021-09902-2.
9. Brodskiy AG, Bolsunovskiy VA, Kosovskikh EA, Urvantseva IA, Tverdokhlib YaV, Tiltaeva LA, Belyaeva EE. Correction of truncal insufficiency using a pulmonary homograph in a patient with a common arterial trunk and interrupted aortic arch. Children’s Heart and Vascular Diseases. 2024; 21 (2): 158–162. (in Russ.). doi: 10.24022/1810-0686-2024-21-2-158-162.
10. Bové T, Demanet H, Wauthy P, Goldstein JP, Dessy H, Viart P et al. Early results of valved bovine jugular vein conduit versus bicuspid homograft for right ventricular outflow tract reconstruction. Ann Thorac Surg. 2002 Aug; 74 (2): 536–541; discussion 541. doi: 10.1016/s0003-4975(02)03728-1.
11. Gist KM, Mitchell MB, Jaggers J, Campbell DN, Yu JA, Landeck BF 2nd. Assessment of the relationship between Contegra conduit size and early valvar insufficiency. Ann Thorac Surg. 2012 Mar; 93 (3): 856–861. doi: 10.1016/j.athoracsur.2011.10.057.
12. Boudjemline Y, Bonnet D, Massih TA, Agnoletti G, Iserin F, Jaubert F et al. Use of bovine jugular vein to reconstruct the right ventricular outflow tract: early results. J Thorac Cardiovasc Surg. 2003 Aug; 126 (2): 490–497. doi: 10.1016/s0022-5223(03)00232-0.
13. Ugaki S, Rutledge J, Al Aklabi M, Ross DB, Adatia I, Rebeyka IM. An increased incidence of conduit endocarditis in patients receiving bovine jugular vein grafts compared to cryopreserved homograft for right ventricular outflow reconstruction. Ann Thorac Surg. 2015 Jan; 99 (1): 140–146. doi: 10.1016/j.athoracsur.2014.08.034.
14. Vitanova K, Cleuziou J, Hörer J, Kasnar-Samprec J, Vogt M, Schreiber C, Lange R. Which type of conduit to choose for right ventricular outflow tract reconstruction in patients below 1 year of age? Eur J Cardiothorac Surg. 2014 Dec; 46 (6): 961–966; discussion 966. doi: 10.1093/ejcts/ezu080.
15. Boethig D, Schreiber C, Hazekamp M, Blanz U, Prêtre R, Asfour B et al. Risk factors for distal Contegra stenosis: results of a prospective European multicentre study. Thorac Cardiovasc Surg. 2012 Apr; 60 (3): 195–204. doi: 10.1055/s-0031-1298062.
16. Van den Eynde J, Callahan CP, Lo Rito M, Hussein N, Carvajal H, Guariento A et al. Tricuspid Valve Intervention at the Time of Pulmonary Valve Replacement in Adults With Congenital Heart Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2021 Dec 21; 10 (24): e022909. doi: 10.1161/JAHA.121.022909.
17. Small AJ, Aksoy O, Levi DS, Salem MM, Yang EH, Aboulhosn JA. Combined Transcatheter Tricuspid and Pulmonary Valve Replacement. World J Pediatr Congenit Heart Surg. 2020 Jul; 11 (4): 432–437. doi: 10.1177/2150135120918777.
Review
For citations:
Shatalov K.V., Arnautova I.V., Patsera S.V., Dzhidzhikhiya K.M., Akhtiamov R.R., Bolsunovskii V.A., Zotov D.V., Gusarova Yu.V. Successful reoperation using homografts for tricuspid and pulmonary valve regurgitation after radical double outlet right ventricle correction. Russian Journal of Transplantology and Artificial Organs. 2025;27(4):196-200. (In Russ.) https://doi.org/10.15825/1995-1191-2025-4-196-200
Views:
24
Email this article 